Value of sentinel lymph node biopsy in breast cancer surgery with simple pathology facilities-an iranian local experience with a review of potential causes of false negative results

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 11, 2012, Pages 5385-5389

  Amoui, Mahasti ^a,c   Akbari, Mohammad Esmail ^a,d   Tajeddini, Araam ^a,e   Nafisi, Nahid ^a,d   Raziei, Ghasem ^a,c   Modares, Seyed Mahdi ^b,c   Hashemi, Mohammad ^b,e  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Khatam Hospital   (Iran)

^c Nuclear Medicine Department   (Iran)

^d Surgery Department   (Iran)

^e Pathology Department   (Iran)

Author keywords

Breast neoplasm; Lymph node dissection; Lymphatic metastasis; Sentinel lymph node biopsy

Indexed keywords

EID: 84874028882     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.11.5385     Document Type: Article

References (39)

1. Abdollahi A, Jangjoo A, Dabbagh Kakhki VR, et al (2010). Factors affecting sentinel lymph node detection failure in breast cancer patients using intradermal injection of the tracer. Rev Esp Med Nucl, 29, 73-7.
2. Ashikaga T, Krag DN, Land SR, et al (2010). Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol, 102, 111-8.
3. Blamey RW, Hornmark-Stenstam B, Ball G, et al (2010). ONCOPOOL-a European database for 16,944 cases of breast cancer. Eur J Cancer, 46, 56-71.
4. Brenot-Rossi I, Houvenaeghel G, Jacquemier J, et al (2003). Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer.? J Nucl Med, 44, 1232-7.
5. Carmon M, Olsha O, Rivkin L, et al (2006). Intraoperative palpation for clinically suspicious axillary sentinel lymph nodes reduces the false-negative rate of sentinel lymph node biopsy in breast cancer. Breast J, 12, 199-201.
6. Clarke D, Newcombe RG, Mansel RE (2004). The learning curve in sentinel node biopsy: the ALMANAC experience. Ann Surg Oncol, 11, 211-5.
7. Cox CE, Kiluk JV, Riker AI (2008). significance of sentinel lymph node micrometastases in human breast cancer. J Am Coll Surg, 206, 261-8.
8. Del Bianco P, Zavagno G, Burelli P, et al (2008). Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol, 34, 508-13.
9. Fisher B, Jeong JH, Anderson S, et al (2002). Twenty-fiveyear follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med, 347, 567-75.
10. Fleissig A, Fallowfield LJ, Langridge CI, et al (2006). Postoperative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat, 95, 279-93.
11. Galimberti V (2006). International Breast Cancer Study Group Trial of sentinel node biopsy. J Clin Oncol, 24, 210-1.
12. Gill G (2009). Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial. Ann Surg Oncol, 16, 266-75.
13. Giuliano AE, Hawes D, Ballman KV, et al (2011). Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. Jama, 306, 385-93.
14. Goyal A, Newcombe RG, Chhabra A, Mansel RE (2006). Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase. Breast Cancer Res Treat, 99, 203-8.
15. Hinson JL, McGrath P, Moore A, et al (2008). The critical role of axillary ultrasound and aspiration biopsy in the management of breast cancer patients with clinically negative axilla. Ann Surg Oncol, 15, 250-5.
16. Husarik DB, Steinert HC (2007). Single-photon emission computed tomography/computed tomographyfor sentinel node mapping in breast cancer. Semin Nucl Med, 37, 29-33.
17. Keshtgar M, Zaknun JJ, Sabih D, et al (2011). Implementing sentinel lymph node biopsy programs in developing countries: challenges and opportunities. World J Surg, 35, 1159-68.
18. Kim T, Giuliano AE, Lyman GH (2006). Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer, 106, 4-16.
19. Krag DN, Anderson SJ, Julian TB, et al (2007). Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol, 8, 881-8.
20. Krag DN, Anderson SJ, Julian TB, et al (2010). Sentinel-lymphnode resection compared with conventional axillary-lymphnode dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol, 11, 927-33.
21. Krag DN, Ashikaga T, Harlow SP, et al (2009). Surgeon training, protocol compliance, and technical outcomes from breast cancer sentinel lymph node randomized trial. J Natl Cancer Inst, 101, 1356-62.
22. Krag DN, Weaver DL, Alex JC, Fairbank JT (1993). Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol, 2, 335-9.
23. Krynyckyi BR, Kim CK, Goyenchea MR, et al (2004). Clinical breast lymphoscintigraphy: optimal techniques for performing studies, image atlas, and analysis of images. Radiographics, 24, 121-45.
24. Langer I, Guller U, Viehl CT, et al (2009). Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study. Ann Surg Oncol, 16, 3366-74.
25. Leidenius MH, Krogerus LA, Toivonen TS, von Smitten KA (2005). Sentinel node biopsy is not sensible in breast cancer patients with large primary tumours. Eur J Surg Oncol, 31, 364-8.
26. Lyman GH, Giuliano AE, Somerfield MR, et al (2005). American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol, 23, 7703-20.
27. Mansel RE, Fallowfield L, Kissin M, et al (2006). Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst, 98, 599-609.
28. Somasundaram SK, Chicken DW, Waddington WA, et al (2009). Sentinel node imaging in breast cancer using superficial injections: technical details and observations. Eur J Surg Oncol, 35, 1250-6.
29. Straver ME, Meijnen P, van Tienhoven G, et al (2010). Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann Surg Oncol, 17, 1854-61.
30. Specht MC, Fey JV, Borgen PI, Cody HS, 3rd (2005). Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy.? J Am Coll Surg, 200, 10-4.
31. Soran A, Falk J, Bonaventura M, et al (2007). Does failure to visualize a sentinel node on preoperative lymphoscintigraphy predict a greater likelihood of axillary lymph node positivity.? J Am Coll Surg, 205, 66-71.
32. Truong PT, Lesperance M (2010). Micrometastatic node-positive breast cancer: long-term outcomes and identification of high-risk subsets in a large population-based series. Ann Surg Oncol, 17, 2138-46.
33. van der Ploeg IM, Olmos RA, Kroon BB, et al (2009). The hidden sentinel node and SPECT/CT in breast cancer patients. Eur J Nucl Med Mol Imaging, 36, 6-11.
34. van der Ploeg IM, Valdes Olmos RA, Kroon BB, Nieweg OE (2008). The Hybrid SPECT/CT as an additional lymphatic mapping tool in patients with breast cancer. World J Surg, 32, 1930-4.
35. van der Heiden, van der Loo M, Bezemer PD, et al (2006). Introduction of sentinel node biopsy and stage migration of breast cancer. Eur J Surg Oncol, 32, 710-4.
36. Veronesi U, Paganelli G, Viale G, et al. (2003). A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med, 349, 546-53.
37. Veronesi U, Viale G, Paganelli G, et al (2010). Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg, 251, 595-600.
38. Zavagno G, Del Bianco P, Koussis H, et al (2008). Clinical impact of false-negative sentinel lymph nodes in breast cancer. Eur J Surg Oncol, 34, 620-5.
39. Zavagno G, De Salvo GL, Scalco G, et al (2008). A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg, 247, 207-13.